Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

Related Citations for PubMed (Select 22972646)

1.

Vascular burden and Alzheimer disease pathologic progression.

Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2012 Sep 25;79(13):1349-55. Epub 2012 Sep 12.

2.

Effect of cognitive reserve markers on Alzheimer pathologic progression.

Lo RY, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):343-50. doi: 10.1097/WAD.0b013e3182900b2b.

3.

Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities.

Tosto G, Zimmerman ME, Carmichael OT, Brickman AM; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Neurol. 2014 Jul 1;71(7):872-7. doi: 10.1001/jamaneurol.2014.667.

PMID:
24821476
4.

Longitudinal change of biomarkers in cognitive decline.

Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Oct;68(10):1257-66. doi: 10.1001/archneurol.2011.123. Epub 2011 Jun 13.

PMID:
21670386
5.

Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism.

Haight TJ, Landau SM, Carmichael O, Schwarz C, DeCarli C, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

JAMA Neurol. 2013 Aug;70(8):1039-45. doi: 10.1001/jamaneurol.2013.1878.

6.

White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Provenzano FA, Muraskin J, Tosto G, Narkhede A, Wasserman BT, Griffith EY, Guzman VA, Meier IB, Zimmerman ME, Brickman AM; Alzheimer's Disease Neuroimaging Initiative.

JAMA Neurol. 2013 Apr;70(4):455-61. doi: 10.1001/jamaneurol.2013.1321.

7.

White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.

Prasad K, Wiryasaputra L, Ng A, Kandiah N.

Dement Geriatr Cogn Disord. 2011;31(6):431-4. doi: 10.1159/000330019. Epub 2011 Jul 15.

PMID:
21757908
8.

Predicting missing biomarker data in a longitudinal study of Alzheimer disease.

Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2012 May 1;78(18):1376-82. doi: 10.1212/WNL.0b013e318253d5b3. Epub 2012 Apr 4.

9.

Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.

Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, Malone IB, Schott JM, Rossor MN, Biessels GJ, DeCarli C, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2013 Aug;34(8):1996-2002. doi: 10.1016/j.neurobiolaging.2013.02.003. Epub 2013 Mar 21.

10.

Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.

Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR Jr, Weiner M, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2010 Nov;67(11):1370-8. doi: 10.1001/archneurol.2010.284.

11.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

PMID:
15324364
12.

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.

Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ.

Neurobiol Aging. 2011 Dec;32(12):2322.e19-27. doi: 10.1016/j.neurobiolaging.2010.05.023. Epub 2010 Jul 1.

13.

Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.

Shaffer JL, Petrella JR, Sheldon FC, Choudhury KR, Calhoun VD, Coleman RE, Doraiswamy PM; Alzheimer’s Disease Neuroimaging Initiative.

Radiology. 2013 Feb;266(2):583-91. doi: 10.1148/radiol.12120010. Epub 2012 Dec 11.

14.

Alzheimer disease biomarkers are associated with body mass index.

Vidoni ED, Townley RA, Honea RA, Burns JM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2011 Nov 22;77(21):1913-20. doi: 10.1212/WNL.0b013e318238eec1.

15.

Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.

Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2013 Feb 12;80(7):648-54. doi: 10.1212/WNL.0b013e318281ccd3. Epub 2013 Jan 9.

16.

Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis.

Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

JAMA Neurol. 2013 Aug;70(8):1030-8. doi: 10.1001/jamaneurol.2013.182.

17.

Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial.

Cyarto EV, Lautenschlager NT, Desmond PM, Ames D, Szoeke C, Salvado O, Sharman MJ, Ellis KA, Phal PM, Masters CL, Rowe CC, Martins RN, Cox KL.

BMC Psychiatry. 2012 Oct 11;12:167. doi: 10.1186/1471-244X-12-167.

18.

Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.

Shokouhi S, Claassen D, Kang H, Ding Z, Rogers B, Mishra A, Riddle WR; Alzheimer’s Disease Neuroimaging Initiative.

J Nucl Med. 2013 Sep;54(9):1564-9. doi: 10.2967/jnumed.112.116137. Epub 2013 Jul 17.

19.

Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.

Appel J, Potter E, Bhatia N, Shen Q, Zhao W, Greig MT, Raj A, Barker WW, Potter H, Schofield E, Wu Y, Loewenstein DA, Duara R.

AJNR Am J Neuroradiol. 2009 Nov;30(10):1870-6. doi: 10.3174/ajnr.A1693. Epub 2009 Jul 30.

20.

Trajectory of white matter hyperintensity burden preceding mild cognitive impairment.

Silbert LC, Dodge HH, Perkins LG, Sherbakov L, Lahna D, Erten-Lyons D, Woltjer R, Shinto L, Kaye JA.

Neurology. 2012 Aug 21;79(8):741-7. doi: 10.1212/WNL.0b013e3182661f2b. Epub 2012 Jul 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk